https://www.selleckchem.com/pr....oducts/Enzastaurin.h
laxis and seem to be slightly superior to pharmacological treatment in compliance and rate of adverse events.Background There is emerging evidence that Guillain-Barré syndrome (GBS) may be associated with coronavirus disease 2019 (COVID-19) infection. The aim of this review was to investigate the strength of the evidence. Method The review was registered in PROSPERO (CDR42020184822). Three electronic databases, MEDLINE, PubMed, and Web of Science, and three preprint servers, MedRvix, ChemRvix, and BioRvix, were searched from Decembe
Like
Comment
Share
